Adolescent Mite Allergy Safety Evaluation

Summary

Adolescent Mite Allergy Safety Evaluation is a clinical trial^[1].

Key Facts

• Adolescent Mite Allergy Safety Evaluation is in the country of Germany^[2].
• Adolescent Mite Allergy Safety Evaluation is in the country of Slovakia^[3].
• Adolescent Mite Allergy Safety Evaluation's instance of is recorded as clinical trial^[4].
• Adolescent Mite Allergy Safety Evaluation's start time is recorded as +2020-09-23T00:00:00Z^[5].
• Adolescent Mite Allergy Safety Evaluation's end time is recorded as +2021-03-31T00:00:00Z^[6].
• Adolescent Mite Allergy Safety Evaluation's main subject is recorded as allergic rhinitis^[7].
• Adolescent Mite Allergy Safety Evaluation's main subject is recorded as Crohn's disease^[8].
• Adolescent Mite Allergy Safety Evaluation's main subject is recorded as rhinitis^[9].
• Adolescent Mite Allergy Safety Evaluation's number of participants is recorded as {'unit': '1', 'amount': '+250'}^[10].
• Adolescent Mite Allergy Safety Evaluation's title is recorded as A 28-day, Single-armed, Open-label Trial to Evaluate Safety of the House Dust Mite (HDM) Sublingual Allergy Immunotherapy (SLIT) Tablet in Adolescent Subjects With HDM Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma^[11].
• Adolescent Mite Allergy Safety Evaluation's short name is recorded as AMASE^[12].
• Adolescent Mite Allergy Safety Evaluation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+12'}^[13].
• Adolescent Mite Allergy Safety Evaluation's ClinicalTrials.gov ID is recorded as NCT04541004^[14].
• Adolescent Mite Allergy Safety Evaluation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+17'}^[15].
• Adolescent Mite Allergy Safety Evaluation's clinical trial phase is recorded as phase III clinical trial^[16].
• Adolescent Mite Allergy Safety Evaluation's research site is recorded as University Hospital Brno^[17].
• Adolescent Mite Allergy Safety Evaluation's research subject recruitment status is recorded as recruiting^[18].
• Adolescent Mite Allergy Safety Evaluation's study type is recorded as interventional study^[19].